Adma Biologics (ADMA) Leases: 2011-2025
Historic Leases for Adma Biologics (ADMA) over the last 5 years, with Sep 2025 value amounting to $9.3 million.
- Adma Biologics' Leases rose 4.20% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 4.20%. This contributed to the annual value of $8.6 million for FY2024, which is 10.39% down from last year.
- According to the latest figures from Q3 2025, Adma Biologics' Leases is $9.3 million, which was up 3.46% from $9.0 million recorded in Q2 2025.
- Adma Biologics' Leases' 5-year high stood at $10.6 million during Q2 2022, with a 5-year trough of $6.2 million in Q1 2021.
- Over the past 3 years, Adma Biologics' median Leases value was $9.3 million (recorded in 2025), while the average stood at $9.3 million.
- Its Leases has fluctuated over the past 5 years, first skyrocketed by 140.42% in 2021, then dropped by 14.65% in 2025.
- Adma Biologics' Leases (Quarterly) stood at $7.3 million in 2021, then soared by 44.37% to $10.5 million in 2022, then dropped by 8.11% to $9.6 million in 2023, then declined by 10.39% to $8.6 million in 2024, then rose by 4.20% to $9.3 million in 2025.
- Its Leases was $9.3 million in Q3 2025, compared to $9.0 million in Q2 2025 and $8.0 million in Q1 2025.